云开药网品牌怎么样 申请店铺

我要投票 云开药网在网上药店行业中的票数:206 更新时间:2025-04-27
云开药网是哪个国家的品牌?「云开药网」是 浙江云开亚美大药房连锁有限公司 旗下著名品牌。该品牌发源于浙江,由创始人刘云江在2012-01-05期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云开药网品牌出海!通过在本页面挂载云开药网品牌的产品链接和联系方式,可以提高云开药网产品曝光!跨境电商爆单神器,目前只要100元/年哦~

云开药网怎么样

浙江云开亚美医药科技股份有限公司(以下简称云开亚美),成立于2011年,上市公司海正药业(股票代码600267)控股企业。是国内领先的重大慢性疾病用药连锁专科药房,旗下有浙江云开亚美大药房连锁有限公司、上海云开亚美大药房有限公司、上海医度迅健康咨询有限公司三大子公司,以经营专科药品为特色,是一家集网上药店、高端连锁、专业药师服务为一体的优秀的医药电商企业,志于打造成为中国专业的医药电子商务零售平台。

云开亚美作为一个针对重大慢性疾病用药的高端零售品牌,专营重大慢特疾病用药及产品(包括药品,保健品,医疗器械等),并基于强大的数据库管理能力和专业的药师服务团队,致力于为客户提供持续、专业的疾病管理服务。

从建立以来,云开亚美一直专注于重大慢性特殊疾病领域,专营慢特疾病用药及产品(包括药品,保健品,医疗器械等),并以专业的医药学知识和真诚服务,基于患者数据库管理,致力于为客户提供持续、专业的疾病管理服务,以人为本的服务理念获得顾客信赖。

所有药师都具有药学专业资格证书,其中拥有执业药师资格占30%,具有扎实的医药基础、优秀的职业素养并在各自领域积累了特有的丰富专科用药知识和经验,致力于提供专业、专精的服务

数十位专业药师免费在线咨询,量身定做电子药历,全程指导用药,并在饮食、运动、日常保健注意等方面给以合理、贴心的专业指导。不仅保证患者可以坚持正确的用药过程,在日常生活各个方面也是遵照科学的方法给予指导,帮助患者全面保持健康。

截止2016年6月,云开亚美已在互联网全渠道建设部署,包括自建交易电商平台(云开药网|无线网店|云开掌上药店APP)、第三方平台旗舰店(天猫、京东、一号店、818、八百方、京卫药房网等)、社交交易平台(微信交易账户网店、支付宝服务窗交易账号网店等),已形成了良好的口碑效应

云开亚美积累了近40种慢特疾病近2000万的慢特疾病患者数据,尤其在股骨头坏死、糖尿病、慢性肾病、慢性肝病等领域极具优势。

云开亚美采用独有的DTC(DirectToConsumer)患教平台,面向慢性特殊疾病终端患者,以数以千万级的详实的患者数据库为核心,通过DTC网站、呼叫中心、短信平台、直邮平台、患者俱乐部及网络互动六大信息沟通渠道,为患者提供国际领先的疾病贴身服务。

专业IT技术团队20人,自建独立订单系统EC-ERP、专业客服接待/呼叫系统、CRM用户管理系统、大型专业物流仓储系统,系统自动跟踪订单、管理后台数据化呈现,用户全程实时跟踪更清晰、更直观、更简单。


Zhejiang Yunkai Yamei Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Yunkai Yamei), founded in 2011, is a holding enterprise of Haizheng Pharmaceutical (Stock Code: 600267). It is a leading chain specialty pharmacy for major chronic diseases in China. It has three subsidiaries, namely Zhejiang Yunkai Yamei pharmacy chain Co., Ltd., Shanghai Yunkai Yamei pharmacy Co., Ltd. and Shanghai yiduxun Health Consulting Co., Ltd. It is an excellent pharmaceutical e-commerce enterprise integrating online pharmacy, high-end chain and professional pharmacist services with the characteristics of specialized drugs The company aims to build a professional pharmaceutical e-commerce retail platform in China. As a high-end retail brand for major chronic disease drugs, Yunkai Yamei specializes in major chronic disease drugs and products (including drugs, health products, medical devices, etc.), and is committed to providing customers with continuous and professional disease management services based on strong database management ability and professional pharmacist service team. Since its establishment, Yunkai Yamei has been focusing on the field of major chronic special diseases, specializing in drugs and products for chronic special diseases (including drugs, health care products, medical devices, etc.), providing continuous and professional disease management services for customers based on professional medical knowledge and sincere service, patient database management, and people-oriented service concept to win customers' trust 。 All pharmacists have pharmaceutical professional qualification certificates, of which 30% are licensed pharmacists. They have solid medical foundation, excellent professional quality and have accumulated unique and rich specialized drug knowledge and experience in their respective fields. They are committed to providing professional and professional services for dozens of professional pharmacists, free online consultation, customized electronic drug calendar, guiding drug use in the whole process, and drinking Food, sports, daily health care and other aspects to give reasonable and thoughtful professional guidance. Not only to ensure that patients can adhere to the correct medication process, in all aspects of daily life is also in accordance with scientific methods to give guidance to help patients to maintain overall health. As of June 2016, Yun Kai Asia and the United States have already deployed in the whole channel of the Internet, including self built trading platform (cloud pharmaceutical network, wireless Internet store, cloud open pocket pharmacy APP), third party platform flagship store (Tmall, Jingdong, No. 1 store, 818, eight hundred party, Jingwei pharmacy network, etc.), social trading platform (WeChat trading account shop, Alipay service window, transaction account shop, etc.) It has formed a good word-of-mouth effect. Yunkai Yamei has accumulated data of nearly 20 million patients with 40 kinds of chronic diseases, especially in the areas of femoral head necrosis, diabetes, chronic kidney disease, chronic liver disease and so on. Yunkai Yamei adopts the unique DTC (directtoconsumer) patient education platform for the terminal patients with chronic special diseases. With tens of millions of detailed patient databases as the core, it provides the patients with the world's leading disease intimate service through six information communication channels: DTC website, call center, SMS platform, direct mail platform, patient club and network interaction. There are 20 professional IT technical teams, with independent order system EC-ERP, professional customer service reception / call system, CRM user management system and large-scale professional logistics storage system. The system automatically tracks orders and manages the background data presentation. The real-time tracking of users is clearer, more intuitive and simpler.

本文链接: https://brand.waitui.com/30598aa74.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

全球首个商用智算昇腾超节点正式发布

4月26日,中国电信粤港澳大湾区智算昇腾超节点发布会,在韶关数据中心集群——中国电信粤港澳大湾区智算中心举行,全球首个商用智算昇腾超节点正式发布。(界面)

42分钟前

科大讯飞发布新一代智慧课堂解决方案

4月25日,在AI赋能基础教育教学变革学术交流大会暨第五届教育装备学术大会上,科大讯飞副总裁周佳峰正式发布新一代智慧课堂解决方案,包括更新后的“星火教师助手”“AI黑板”和“AI学伴”。其中上线后的 AI 学伴,覆盖课前预习、课中学习、课后复习、精准备考、家校共育等全场景。

42分钟前

全球首款三涵道穿戴式单人飞行器在杭州成功首飞

国内首创基于三涵道构型的穿戴式单人飞行器在杭州成功首飞。该飞行器由杭州智元研究院研发,续航里程≥8km,最大飞行高度≥1km,续航时间≥20min,最大速度≥60km/h。杭州智元研究院高级工程师田聪玲介绍,其采用涵道动力与舵面融合控制,有高效、可靠的特点。在人机交互方面,该飞行器可配合AR头盔和摇杆操作实现智能交互,在自动驾驶状态下能解放双手,实现高空作业。从应用看,其可应用于应急救援、飞行体验、低空经济空中作业等场景。(财联社)

42分钟前

美国电商平台集体提价

近期特朗普关税政策导致全球贸易紧张局势加剧,商家运营成本上升。据美国媒体4月25日报道,美国亚马逊等电商平台上不少商家已经开始提高商品的售价。根据一家价格分析机构提供的数据,自4月9日以来,美国亚马逊网站上近1000种商品的价格出现明显上涨,涵盖服装、家居用品、电子产品和玩具等多个类别,平均涨价幅度接近30%。包括Temu、希音等多个跨境电商平台均已发布公告称,由于“近期全球贸易规则及关税变动”导致运营成本上升,将从4月25日开始实施价格调整。社交媒体上也有大量美国网友感叹道,一夜之间购物车里的东西都变贵了。 (央视财经)

42分钟前

新版国家卫生监督抽查计划发布 首次明确打击网络“医托”

国家疾控局等3部门近日联合发布医疗卫生领域《2025年国家随机监督抽查计划》。相较于2024年计划,2025年计划在监管范围等方面作出调整,新增互联网诊疗、精神卫生等监管领域,并首次明确打击网络“医托”等新型违法行为,进一步强化公共卫生和医疗秩序治理。(财联社)

42分钟前

本页详细列出关于云开药网的品牌信息,含品牌所属公司介绍,云开药网所处行业的品牌地位及优势。
咨询